ATE175112T1 - Verwendung von taurin zur herstellung eines medikaments zur stimulierung der myeloperoxidaseaktivität - Google Patents
Verwendung von taurin zur herstellung eines medikaments zur stimulierung der myeloperoxidaseaktivitätInfo
- Publication number
- ATE175112T1 ATE175112T1 AT91306903T AT91306903T ATE175112T1 AT E175112 T1 ATE175112 T1 AT E175112T1 AT 91306903 T AT91306903 T AT 91306903T AT 91306903 T AT91306903 T AT 91306903T AT E175112 T1 ATE175112 T1 AT E175112T1
- Authority
- AT
- Austria
- Prior art keywords
- acid
- aminoethanesulphonic
- ethanesulphonic
- propanesulphonic
- taurine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE274190 | 1990-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE175112T1 true ATE175112T1 (de) | 1999-01-15 |
Family
ID=11036287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91306903T ATE175112T1 (de) | 1990-07-30 | 1991-07-29 | Verwendung von taurin zur herstellung eines medikaments zur stimulierung der myeloperoxidaseaktivität |
Country Status (8)
Country | Link |
---|---|
US (1) | US5248680A (de) |
EP (1) | EP0469813B1 (de) |
JP (1) | JPH0597666A (de) |
AT (1) | ATE175112T1 (de) |
AU (1) | AU641529B2 (de) |
CA (1) | CA2048068A1 (de) |
DE (1) | DE69130692T2 (de) |
ES (1) | ES2128309T3 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7404967B2 (en) | 1994-12-21 | 2008-07-29 | Cosmederm, Inc. | Topical product formulations containing strontium for reducing skin irritation |
EP0806947A4 (de) * | 1995-02-03 | 1998-10-14 | Cosmederm Technologies | Formulierungen und verfahren zur verminderung von hautirritationen |
US5716959A (en) * | 1996-02-13 | 1998-02-10 | T. Ronald Theodore | Method of treating disease with piperazine zwitterion compounds |
SE9601395D0 (sv) * | 1996-04-12 | 1996-04-12 | Dieter Haeussinger | New therapeutic treatment 1 |
US6111085A (en) * | 1996-09-13 | 2000-08-29 | Isis Pharmaceuticals, Inc. | Carbamate-derivatized nucleosides and oligonucleosides |
US20050124608A1 (en) * | 2001-04-03 | 2005-06-09 | Redmond H. P. | Treatment of cancers |
US20030027818A1 (en) * | 2001-04-03 | 2003-02-06 | Redmond H. Paul | Treatment of cancers |
US6114337A (en) * | 1998-11-27 | 2000-09-05 | Pugliese; Peter T. | Zwitteronic-fatty acid compounds having anti-inflammatory properties |
EP1033913A1 (de) * | 1997-11-28 | 2000-09-13 | Peter T. Pugliese | Zwitterionische fettsäure-verbindungen zur entzündungshemmung |
US6448251B1 (en) * | 1997-11-28 | 2002-09-10 | Peter T. Pugliese | Zwitterionic-fatty acid compounds having anti-inflammatory properties |
CA2386985A1 (en) * | 2000-08-11 | 2002-02-21 | The Lawson Health Research Institute | Compositions and methods for inhibiting islet dysfunction and autoimmune disorders |
DE50111407D1 (de) * | 2000-09-14 | 2006-12-21 | Waldemar Gottardi | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen |
FR2816837A1 (fr) * | 2000-11-17 | 2002-05-24 | Oreal | Utilisation d'au moins un derive amino sulfonique dans une composition destinee a favoriser la desquamation de la peau |
GB0109428D0 (en) * | 2001-04-17 | 2001-06-06 | Process & Ind Design Consultan | Therapeutic compositions |
DE10133197A1 (de) * | 2001-07-07 | 2003-01-23 | Beiersdorf Ag | Aminosäuren enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut |
US20060127342A1 (en) * | 2004-12-09 | 2006-06-15 | Georgia Levis | Taurine-based compositions, therapeutic methods, and assays |
JP2010516428A (ja) * | 2007-01-31 | 2010-05-20 | ヘラー, アダム | 疼痛の電気化学的管理 |
CN107260740A (zh) | 2009-09-17 | 2017-10-20 | 比斯普科生物科学有限公司 | N‑2‑羟基‑乙基‑哌嗪‑n’‑2‑乙磺酸(hepes) 在疼痛控制和脱髓鞘损伤逆转中的作用 |
WO2013118953A1 (ko) * | 2012-02-07 | 2013-08-15 | 연세대학교 산학협력단 | 호압성 황산화 화학독립영양미생물을 이용하여 고압 이산화탄소를 바이오매스로 고정 또는 전환하는 방법 |
JP2014040393A (ja) * | 2012-08-23 | 2014-03-06 | Taisho Pharmaceutical Co Ltd | 遺伝子発現調節剤 |
TW201619605A (zh) * | 2014-10-24 | 2016-06-01 | Shiseido Co Ltd | 用以改善起因於角質層剝離之抑制或促進之肌膚狀態的美容方法及評價方法 |
RU2614691C2 (ru) * | 2015-07-14 | 2017-03-28 | Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") | Гепатопротекторное средство |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE52977B1 (en) * | 1981-11-24 | 1988-04-27 | Pascale Ltd | Protective composition for users of cyanoacrylate adhesives |
JPS592686A (ja) * | 1982-06-25 | 1984-01-09 | Green Cross Corp:The | ミエロペルオキシダ−ゼの粉末製剤 |
EP0100827B1 (de) * | 1982-08-17 | 1986-09-03 | Rosical Limited | Pharmazeutische Zusammensetzung eine alifatische Aminosulfonsäure enthaltend |
IE853206L (en) * | 1985-12-18 | 1987-06-18 | Sullivan Donncha O | Use of aminosulfonic acids in treatment of inflammatory¹conditions |
GB8713091D0 (en) * | 1987-06-04 | 1987-07-08 | Millrine W P | Pharmaceutical compositions |
WO1990003185A1 (en) * | 1988-09-28 | 1990-04-05 | Ideon Corporation | Combination enzyme immunotherapeutics |
-
1991
- 1991-07-25 AU AU81332/91A patent/AU641529B2/en not_active Ceased
- 1991-07-26 US US07/736,247 patent/US5248680A/en not_active Expired - Fee Related
- 1991-07-29 CA CA002048068A patent/CA2048068A1/en not_active Abandoned
- 1991-07-29 EP EP91306903A patent/EP0469813B1/de not_active Expired - Lifetime
- 1991-07-29 AT AT91306903T patent/ATE175112T1/de not_active IP Right Cessation
- 1991-07-29 ES ES91306903T patent/ES2128309T3/es not_active Expired - Lifetime
- 1991-07-29 DE DE69130692T patent/DE69130692T2/de not_active Expired - Fee Related
- 1991-07-29 JP JP3188644A patent/JPH0597666A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE69130692D1 (de) | 1999-02-11 |
EP0469813B1 (de) | 1998-12-30 |
AU641529B2 (en) | 1993-09-23 |
ES2128309T3 (es) | 1999-05-16 |
DE69130692T2 (de) | 1999-09-09 |
EP0469813A2 (de) | 1992-02-05 |
AU8133291A (en) | 1992-02-13 |
EP0469813A3 (en) | 1992-11-19 |
CA2048068A1 (en) | 1992-01-31 |
JPH0597666A (ja) | 1993-04-20 |
US5248680A (en) | 1993-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE175112T1 (de) | Verwendung von taurin zur herstellung eines medikaments zur stimulierung der myeloperoxidaseaktivität | |
ATE249215T1 (de) | Verwendung von app-modulatoren zur herstellung eines medikamentes zur behandlung der amyloidose | |
PT74181B (pt) | Herstellung und verwendung von neuen phenylpyrimidinen als ge- genmittel zum schutz von kulturpflanzen gegen durch herbizide verursachte phytotoxische schaeden | |
ATE133336T1 (de) | Verwendung von rapamycin zur herstellung eines arzneimittels zur behandlung von augenentzündungen | |
ATE83659T1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
DE69132696D1 (de) | Photodynamische Inaktivierung von Viren in Zellenzusammensetzungen | |
DE69125890D1 (de) | Stamm von Trichoderma harzianum, T-39, diese enthaltende Zusammensetzungen und deren Verwendung gegen B. Cinerea und S. Sclerotiorum | |
DE69932414D1 (de) | Indole-3-propionsäure, ihre salze und ester als arzneimittel | |
DE69719931D1 (de) | Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren | |
ATE157007T1 (de) | 6-cyclohexyl-2'-0-methyl-adenosine hydrat und verwendungengen davon | |
ATE191849T1 (de) | Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst | |
ATE173401T1 (de) | Neue verwendung von 1-alpha-hydroxylierten-19-nor-vitamin-d-verbind ngen zur behandlung von psoriasis | |
ATE3289T1 (de) | Alpha-azolylglykolderivate, ihre herstellung, sie enthaltende pflanzenwachstumsregulierende mittel und ihre verwendung. | |
DE69420679D1 (de) | Verwendung der 1-4-4-Aryl(oder Heteroaryl)-1-Piperazinylbutyl-1H-Azol-Derivate zur Herstellung von Arzneimitteln zur Behandlung der Störungen der Magensekretion | |
ATE109132T1 (de) | N-substituierte pyrrolidin- und piperidinderivate und deren salze. | |
ATE23112T1 (de) | Verwendung von 1-(p-isopropoxyethoxymethylphenoxy)-3-isopropylamino-propan-2-ol zur herstellung eines arzneimittels zur senkung des augeninnendrucks. | |
ES2109530T3 (es) | Derivados de acidos fenil-ciclohexano-carboxilicos heterotriciclicamente sustituidos. | |
ATE155128T1 (de) | Buttersäurederivate, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfung | |
ATE232097T1 (de) | Verwendung von sulfaminsäuren derivaten, acrylsulfonamiden oder sulfonylcarbonaten zur herstellung eines arzneimittels zur senkung des spiegels von lipoproteinen | |
ATE171704T1 (de) | Optisch wirksame alkylendioxybenzolderivate und ihre verwendung als arzneimittel | |
DE69008466D1 (de) | Verwendung des 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-Dimethyluracils zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Harnwegsverstopfungen. | |
DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
ATE117307T1 (de) | Serinderivate, verfahren zu ihrer herstellung und ihre verwendung in der humantherapie. | |
ATE158719T1 (de) | Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung | |
ATE25501T1 (de) | Verwendung von 2-(n-(2,6-dichlorphenyl)-n-allylamino)-imidazolin-(2) zur herstellung von bradykarden arzneimitteln. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |